Data gathered: February 1
Alternative Data for Sellas Life Sciences Group
| Alternative Data | Value | 3m Change | Trend | Benchmark |
|---|---|---|---|---|
| Sentiment | 87 | Sign up | Sign up | Sign up |
| Webpage traffic | 22,000 | Sign up | Sign up | Sign up |
| Google Trends | N/A | Sign up | Sign up | Sign up |
| 4chan Mentions | N/A | Sign up | Sign up | Sign up |
| Reddit Mentions | 15 | Sign up | Sign up | Sign up |
| Stocktwits Mentions | 153 | Sign up | Sign up | Sign up |
| Stocktwits Subscribers | 44,162 | Sign up | Sign up | Sign up |
| Twitter Mentions | 24 | Sign up | Sign up | Sign up |
| News Mentions | N/A | Sign up | Sign up | Sign up |
| Customer reviews | N/A | Sign up | Sign up | Sign up |
About Sellas Life Sciences Group
SELLAS Life Sciences Group, Inc., an advanced-stage biopharmaceutical company, focuses on the development of new cancer immunotherapies for various indications of cancer in the United States. The company is headquartered in New York, New York.
| Price | $1.62 |
| Target Price | Sign up |
| Volume | 6,840,000 |
| Market Cap | $127M |
| Year Range | $0.84 - $1.62 |
| Dividend Yield | 0% |
| Analyst Rating | 100% buy |
| Industry | Biotechnology |
In the news
 |
Investors Buy High Volume of Put Options on SELLAS Life Sciences Group (NASDAQ:SLS)January 24 - ETF Daily News |
|
State Street Corp Boosts Position in SELLAS Life Sciences Group, Inc. (NASDAQ:SLS)January 4 - ETF Daily News |
|
SELLAS Life Sciences Group, Inc. (NASDAQ:SLS) Short Interest Down 17.6% in DecemberDecember 31 - ETF Daily News |
|
XTX Topco Ltd Invests $78,000 in SELLAS Life Sciences Group, Inc. (NASDAQ:SLS)December 22 - ETF Daily News |
SELLAS Life Sciences Group Announces $25 Million Registered Direct Offering Priced At-the-Market Under Nasdaq RulesJanuary 28 - GlobeNewswire |
|
SELLAS Life Sciences Announces Positive Outcome of Interim Analysis for its Pivotal Phase 3 REGAL Trial of GPS in Acute Myeloid LeukemiaJanuary 23 - GlobeNewswire |
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | EPS | |
|---|---|---|---|---|---|---|
| Q3 '24 | 0 | 3M | -3M | -7.1M | 0 | 0.000 |
| Q2 '24 | 0 | 2.4M | -2.4M | -7.5M | -7.6M | -0.130 |
| Q1 '24 | 79,000 | 4.5M | -4.5M | -9.6M | -9.6M | -0.210 |
| Q4 '23 | 41,000 | 3.1M | -3M | -8.1M | -8.2M | -0.250 |
| Q3 '23 | 94,000 | 3.5M | -3.5M | -9.3M | 94,000 | -0.330 |
Insider Transactions View All
| WOOD BARBARA A filed to sell 56,344 shares at $2.6. December 5 '22 |
| Burns John Thomas filed to sell 29,347 shares at $2.6. December 5 '22 |
| Stergiou Angelos M. filed to sell 161,689 shares at $2.6. December 5 '22 |
Similar companies
Read more about Sellas Life Sciences Group (SLS) and their ai stock analysis, price prediction, earnings, congress trading, insider transactions, technical analysis, sentiment, webpage traffic, google trends, 4chan mentions, reddit mentions, stocktwits mentions, stocktwits subscribers, twitter mentions, news mentions & customer reviews.
What is the Market Cap of Sellas Life Sciences Group?
The Market Cap of Sellas Life Sciences Group is $127M.
What is the current stock price of Sellas Life Sciences Group?
Currently, the price of one share of Sellas Life Sciences Group stock is $1.62.
How can I analyze the SLS stock price chart for investment decisions?
The SLS stock price chart above provides a comprehensive visual representation of Sellas Life Sciences Group's stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Sellas Life Sciences Group shares. Our platform offers an up-to-date SLS stock price chart, along with technical data analysis and alternative data insights.
Does SLS offer dividends to its shareholders?
As of our latest update, Sellas Life Sciences Group (SLS) does not offer dividends to its shareholders. Investors interested in Sellas Life Sciences Group should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.
What are some of the similar stocks of Sellas Life Sciences Group?
Some of the similar stocks of Sellas Life Sciences Group are Amgen, Gilead Sciences, Catalyst Pharmaceuticals, Inovio Pharmaceuticals, and Anavex Life Sciences.
.